These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26402980)

  • 1. Cytokines in inflammatory bowel disease.
    Moldoveanu AC; Diculescu M; Braticevici CF
    Rom J Intern Med; 2015; 53(2):118-27. PubMed ID: 26402980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The cytokines in inflammatory bowel disease].
    Polińska B; Matowicka-Karna J; Kemona H
    Postepy Hig Med Dosw (Online); 2009 Aug; 63():389-94. PubMed ID: 19724079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytokines and gut].
    Shimada T; Hiraishi H; Terano A
    Nihon Rinsho; 1998 Sep; 56(9):2235-9. PubMed ID: 9780698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune mechanisms in chronic inflammatory bowel disease.
    Braegger CP; MacDonald TT
    Ann Allergy; 1994 Feb; 72(2):135-41. PubMed ID: 8109803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mathematical model of the roles of T cells in inflammatory bowel disease.
    Lo WC; Arsenescu RI; Friedman A
    Bull Math Biol; 2013 Sep; 75(9):1417-33. PubMed ID: 23760658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune dysfunction in inflammatory bowel disease.
    Neuman MG
    Transl Res; 2007 Apr; 149(4):173-86. PubMed ID: 17383591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A CD3-specific antibody reduces cytokine production and alters phosphoprotein profiles in intestinal tissues from patients with inflammatory bowel disease.
    Vossenkämper A; Hundsrucker C; Page K; van Maurik A; Sanders TJ; Stagg AJ; Das L; MacDonald TT
    Gastroenterology; 2014 Jul; 147(1):172-83. PubMed ID: 24704524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling for inflammation and repair in inflammatory bowel disease.
    Neuman MG
    Rom J Gastroenterol; 2004 Dec; 13(4):309-16. PubMed ID: 15624029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal models of intestinal inflammation: clues to the pathogenesis of inflammatory bowel disease.
    Powrie F; Uhlig H
    Novartis Found Symp; 2004; 263():164-74; discussion 174-8, 211-8. PubMed ID: 15669641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokines in inflammatory bowel disease.
    Kmieć Z
    Arch Immunol Ther Exp (Warsz); 1998; 46(3):143-55. PubMed ID: 9704146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokines and inflammatory bowel disease: a review.
    McClane SJ; Rombeau JL
    JPEN J Parenter Enteral Nutr; 1999; 23(5 Suppl):S20-4. PubMed ID: 10483888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy of inflammatory bowel diseases: current concepts and future perspectives.
    Neurath MF
    Arch Immunol Ther Exp (Warsz); 2000; 48(2):81-4. PubMed ID: 10807047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolome and inflammasome in inflammatory bowel disease.
    Nanau RM; Neuman MG
    Transl Res; 2012 Jul; 160(1):1-28. PubMed ID: 22687960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of dendritic cells in the pathogenesis of inflammatory bowel disease.
    Leon F; Smythies LE; Smith PD; Kelsall BL
    Adv Exp Med Biol; 2006; 579():117-32. PubMed ID: 16620015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New mediators of immunity and inflammation in inflammatory bowel disease.
    Monteleone G; Fina D; Caruso R; Pallone F
    Curr Opin Gastroenterol; 2006 Jul; 22(4):361-4. PubMed ID: 16760750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effector T Helper Cell Subsets in Inflammatory Bowel Diseases.
    Imam T; Park S; Kaplan MH; Olson MR
    Front Immunol; 2018; 9():1212. PubMed ID: 29910812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological disorders in inflammatory bowel disease and immunotherapeutic implications.
    Amati L; Caradonna L; Jirillo E; Caccavo D
    Ital J Gastroenterol Hepatol; 1999 May; 31(4):313-25. PubMed ID: 10425578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cigarette smoking as a promoting factor for nonspecific inflammatory bowel disease].
    Molenda M; Bober J; Stańkowska-Walczak D; Stańczyk-Dunaj M
    Ann Acad Med Stetin; 2010; 56(3):50-4. PubMed ID: 22053626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current concept of the role of monocytes/macrophages in inflammatory bowel disease--balance of proinflammatory and immunosuppressive mediators.
    Lügering N; Kucharzik T; Stoll R; Domschke W
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):338-44. PubMed ID: 9759608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th17 cytokines in inflammatory bowel diseases: discerning the good from the bad.
    Troncone E; Marafini I; Pallone F; Monteleone G
    Int Rev Immunol; 2013; 32(5-6):526-33. PubMed ID: 24041379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.